NeuroOne Medical Technolo...

NASDAQ: NMTC · Real-Time Price · USD
0.85
0.02 (2.41%)
At close: Aug 15, 2025, 9:48 AM

NeuroOne Medical Balance Sheet Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Cash & Equivalents
1.46M 5.32M 8.16M 6.9M
Short-Term Investments
n/a n/a 2.98M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
176.64K n/a 33.24K 48.34K
Inventory
2.64M 1.73M 704.54K 98.29K
Other Current Assets
142.63K n/a n/a 92.93K
Total Current Assets
4.63M 7.31M 12.18M 7.29M
Property-Plant & Equipment
671.75K 694.81K 534.95K 512.28K
Goodwill & Intangibles
67.26K 89.58K 111.89K 134.21K
Total Long-Term Assets
739.01K 784.39K 646.85K 646.48K
Total Assets
5.37M 8.1M 12.82M 7.94M
Account Payables
1.03M 685.1K 927.66K 528.83K
Deferred Revenue
n/a n/a 1.46M 8.62K
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
233.75K n/a n/a n/a
Total Current Liabilities
2.21M 1.79M 3.1M 1.18M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
2.14M n/a n/a n/a
Total Long-Term Liabilities
2.33M 55.28K 119.56K 202.9K
Total Liabilities
4.55M 1.85M 3.22M 1.38M
Total Debt
260.16K 184.4K 202.9K 315.67K
Common Stock
30.82K 23.93K 16.22K 12.01K
Retained Earnings
-75M -62.69M -50.83M -40.83M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
822.01K 6.25M 9.6M 6.55M
Total Investments
n/a n/a 2.98M n/a